Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.54
-0.87 (-4.26%)
At close: Nov 11, 2026, 4:00 PM EST
19.09
-0.45 (-2.29%)
After-hours: Nov 11, 2026, 5:16 PM EST

Legend Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3591,029627.3285.1117.0168.83
Revenue Growth
49.44%64.02%120.03%143.66%70.00%-8.23%
Gross Profit
774.1620.8392.7140.951.6468.83
Operating Income
37.3-136.5-305.1-528.1-458.05-394.02
Net Income
-0.2-296.8-177-518.3-446.35-403.58
Earnings Per Share
-0.01-1.62-0.97-2.94-2.81-2.87
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
License
10383.8138.435.165065.4
Collaboration
1,255944.8482.58249.866.68-
Other Service
-0.36.260.180.333.42
Revenue (Total)
1,3581,029627.3285.1117.0168.83

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
852.5948.61,1231,3091,026882.4
Total Debt
167.4413.7350.6328.67284.53122.97
Net Cash (Debt)
685.1534.9772980.05741.12759.43
Net Cash Growth
17.64%-30.71%-21.23%32.24%-2.41%51.28%
Net Cash Per Share
3.652.904.225.574.665.39

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-154.1-100.2-144-393.3-201.28-198.47
Capital Expenditures
-33-28.6-14.1-20.1-20.93-42.2
Free Cash Flow
-187.1-128.8-158.1-413.4-222.21-240.66
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.98%60.34%62.60%49.42%44.14%100.00%
Operating Margin
2.75%-13.27%-48.64%-185.23%-391.48%-572.49%
Pretax Margin
2.37%-27.47%-25.20%-182.46%-380.94%-591.63%
Profit Margin
-0.01%-28.85%-28.22%-181.80%-381.48%-586.38%
FCF Margin
-13.77%-12.52%-25.20%-145.00%-189.91%-349.67%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
28.35150.43----
PS Ratio
2.723.909.5238.3771.42104.26